Australians Urged to Get Vaccinated Against Fast-Spreading ‘Super-K’ Flu

Health officials are issuing an urgent call for widespread vaccination as a highly contagious influenza variant, known as subclade K or Super-K flu, begins to circulate through the community. While the strain is not necessarily more lethal on an individual basis, its ability to spread rapidly has experts concerned that the sheer volume of infections could overwhelm healthcare systems and increase the total number of severe outcomes.

The warning comes on the heels of a devastating period for public health in Australia, which recorded its most severe flu season on record last year. According to health data, more than 500,000 people contracted the flu in Australia last year, resulting in 1,738 deaths. The momentum is already building for the current cycle, with more than 24,000 cases reported well before the typical peak of the season.

As a physician, I have seen how the “numbers game” works in epidemiology: when a virus becomes more efficient at spreading, the total number of hospitalizations rises even if the virus’s inherent virulence remains the same. For the Super-K variant, the primary threat is its genetic efficiency, which allows it to move through populations faster than previous strains.

Professor Paul Griffin, Director of Infectious Diseases at the Mater in Brisbane, emphasizes that the current window for protection is critical. He notes that the annual vaccine has been specifically updated to provide better coverage against these emerging strains compared to previous formulations.

LISTEN TO

INTERVIEW: Professor Paul Griffin tells SBS ‘more important than ever’ to get flu vaccine this year

The genetic shift of subclade K

The primary concern regarding the Super-K flu is its genetic makeup. Robert Booy, an infectious diseases paediatrician at the University of Sydney, explains that the influenza K subclade is genetically altered to facilitate easier transmission. This mutation allows the virus to jump between hosts more effectively, increasing the attack rate within households and workplaces.

Booy clarifies that the strain is not inherently more severe in terms of the disease it causes in a single patient. However, because the virus reaches so many more people, the absolute number of severe cases—including pneumonia and respiratory failure—inevitably climbs. This creates a paradoxical situation where a “non-severe” strain can cause a severe public health crisis due to its transmissibility.

A growing vulnerability gap

Experts are particularly worried about the “under-vaccination” trend that has persisted since the COVID-19 pandemic. A combination of vaccine fatigue and the spread of medical misinformation has led to a decline in the number of people seeking their annual flu shot, leaving a significant portion of the population susceptible.

The risk is not distributed evenly. Those aged 50 and older are considered the most vulnerable, not only because of the increased risk of complications but also because of a phenomenon called immunosenescence—the gradual deterioration of the immune system with age. Jules Bayliss, vaccines medical director at CSL Seqirus, notes that older adults are at a higher risk of disease and may not respond as robustly to vaccination as younger individuals, making the shot even more essential for them.

Annual Flu Vaccination Rates by Age Group (Previous Season)

Age Group	Vaccination Rate
65 years and older	60.5%
50 to 64 years	32.3%

The disparity in vaccination rates—particularly the low uptake among those aged 50 to 64—creates a dangerous gap in community immunity. When a fast-spreading variant like Super-K enters a population with these gaps, the virus finds ample opportunity to circulate and reach the most frail members of society.

Practical steps for protection

To mitigate the impact of the current season, health experts are urging the public to adhere to a specific timeline for immunization. April and May are regarded as the ideal window to receive the flu vaccine, ensuring that the body has developed a full immune response before the winter peak arrives.

Beyond vaccination, Professor Griffin recommends a multi-layered approach to reducing transmission. This includes staying home when feeling unwell to prevent workplace and school outbreaks, as well as seeking early testing for those in high-risk categories. For those who are severely ill or highly vulnerable, the timely administration of antiviral medications can be life-saving.

For the most accurate and current guidance, individuals are encouraged to consult their general practitioners or local pharmacists, who can provide tailored health advice based on personal medical history and current local transmission levels. Official updates on strain prevalence can be monitored via the World Health Organization’s Global Influenza Programme.

Disclaimer: This article is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

Public health agencies will continue to monitor the genetic drift of subclade K throughout the winter months. The next major update on vaccine efficacy and strain dominance is expected following the mid-season surveillance reports from national health departments.

Do you have questions about this year’s flu vaccine? Share this article with your family or leave a comment below to join the conversation.